Moderate kidney disease costs Medicare billions a year
Expenses related to moderate chronic kidney disease (CKD) cost Medicare tens of billions of dollars each year, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
New study suggests 59% of Americans will develop kidney disease in their lifetime
Nearly six out of 10 Americans will develop kidney disease in their lifetime, according to a new analysis published in the American Journal of Kidney Diseases. In comparison, lifetime risk of diabetes, heart attack and invasive cancer is approximately four in 10.
CMS, Arbor Research soliciting comments on newly proposed quality measures for ESRD
New quality measures developed by Arbor Research related to treating kidney disease and dialysis patients are available for review and comment through August 12.
New definition of chronic kidney disease labels 1 in 8 adults as sick
A new definition of chronic kidney disease labels over 1 in 8 adults and around half of people over 70 years of age as having the disease. Yet low rates of kidney failure suggest many of those diagnosed will never progress to severe disease.
Innovation in mouse model helps researchers distinguish disease mechanisms and biomarkers
A team led by researchers at the National Institutes of Health has overcome a major biological hurdle in an effort to find improved treatments for patients with a rare disease called methylmalonic acidemia (MMA).
The frequency and duration of patient-doctor contact during dialysis care key to patients’ health
Both the frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries, and facilities with more frequent and longer contact had fewer patient deaths and hospitalizations, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Potential for new, less invasive ways to detect and treat bladder cancer
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
Study Clarifies Surgical Options for Kidney Cancer
Surgery is often the first step in treating kidney cancer, and new data from the University of Rochester Medical Center, which contradicts earlier research, questions whether removal of only the tumor (partial nephrectomy) is better than removing the entire kidney (radical nephrectomy).
Device Aids Calculation of Insulin Bolus
Using an automated calculator built into a blood glucose meter helped people with diabetes control their blood sugar, researchers reported.
lucy jasmine says
hiii,
Great stuff about Nephrology/Health. Thank you for sharing this with us. 😀